Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis. uri icon

Overview

publication date

  • September 28, 2020

Research

keywords

  • Angiotensin-Converting Enzyme 2
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • COVID-19
  • COVID-19 Drug Treatment
  • Psoriasis
  • RNA, Messenger
  • SARS-CoV-2
  • Skin

Identity

PubMed Central ID

  • PMC7834246

Scopus Document Identifier

  • 85094599363

Digital Object Identifier (DOI)

  • 10.1016/j.jaci.2020.09.021

PubMed ID

  • 33002515

Additional Document Info

volume

  • 147

issue

  • 3